File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial

TitleBrivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial
Authors
Issue Date2014
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
Citation
Hepatology, 2014, v. 60 n. 5, p. 1697-1707 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/200953
ISSN
2017 Impact Factor: 14.079
2015 SCImago Journal Rankings: 4.752
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorKudo, M-
dc.contributor.authorHan, G-
dc.contributor.authorFinn, RS-
dc.contributor.authorPoon, RTP-
dc.date.accessioned2014-08-21T07:07:44Z-
dc.date.available2014-08-21T07:07:44Z-
dc.date.issued2014-
dc.identifier.citationHepatology, 2014, v. 60 n. 5, p. 1697-1707-
dc.identifier.issn0270-9139-
dc.identifier.urihttp://hdl.handle.net/10722/200953-
dc.languageeng-
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/-
dc.relation.ispartofHepatology-
dc.titleBrivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial-
dc.typeArticle-
dc.identifier.emailPoon, RTP: poontp@hku.hk-
dc.identifier.authorityPoon, RTP=rp00446-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1002/hep.27290-
dc.identifier.pmid24996197-
dc.identifier.hkuros233324-
dc.identifier.volume60-
dc.identifier.issue5-
dc.identifier.spage1697-
dc.identifier.epage1707-
dc.identifier.isiWOS:000344352400027-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats